首页 | 本学科首页   官方微博 | 高级检索  
检索        

利奈唑胺在Beagle犬体内的药动学研究
引用本文:田涛,王红字,徐红.利奈唑胺在Beagle犬体内的药动学研究[J].中国药业,2013(22):44-46.
作者姓名:田涛  王红字  徐红
作者单位:[1]中国人民解放军成都军区药材仓库业务处,四川成都610017 [2]中国人民解放军成都军区联勤部药品检验所,四川成都610017
摘    要:目的建立测定Beagle犬血浆中利奈唑胺质量浓度的高效液相色谱法,研究其在Beagle犬体内的药物代谢动力学特征。方法5只Beagle犬灌胃给予利奈唑胺50mg/kg,于给药前及给药后0.083,0.17,0.33,0.66,1.0,1.5,2.0,4.0,6.0,8.0,12.0,24h采集血样,用高效液相色谱法测定血浆中利奈唑胺的质量浓度,血浆样品用10%三氯乙酸沉淀蛋白,流动相为甲醇-乙腈-水(20:20:60,V/V/V),检测波长25411In。采用DAS3.0程序计算药物代谢动力学参数。结果利奈唑胺质量浓度线性范围是0.20~40.0μg/mL(r=0.9993),平均绝对回收率为90.50%~95.20%,日内和日间RSD均小于12%。利奈唑胺在犬体内的主要药动学参数值,达峰浓度(Gmax)为(25.36±9.65)μg/mL,半衰期(t。,2)为(3.72±1.06)h,0~24h药时曲线下面积(AUCo-24)为(144.65±39.85)mg·h/L,0-∞药时曲线下面积(AUCo-∞)为(146.98±45.18)mg·h/L。结论该方法简便、快速,适用于体内利奈唑胺的测定及药动学研究。利奈唑胺在犬体内符合一室模型,消除较快,分布较广。

关 键 词:利奈唑胺  高效液相色谱法  药物代谢动力学

Study on in vivo Pharmacokinetics of Linezolid in Beagle dog
Tian Tao,Wang Hongyu,Xu Hong.Study on in vivo Pharmacokinetics of Linezolid in Beagle dog[J].China Pharmaceuticals,2013(22):44-46.
Authors:Tian Tao  Wang Hongyu  Xu Hong
Institution:2 ( 1. Operation Office, Medicinal Material Warehouse of Chengdu Military Region, Chengdu, Sichnan, China 610017; 2. Institute for Drug Control, Joint Survices Department of Chengdu Military Region, Chengdu, Sichuan, China 610017)
Abstract:Objective To establish a HPLC method to detect the plasma concentration of linezolid in beagle dog and to study its pharmacokinetics in vivo. Methods 5 Beagle dogs were given linezolid 50 mg/kg by gavage. The blood sample was collected before drug administration and at 0,0. 083,0.17,0.33,0.66,1.0,1.5,2.0,4.0,6.0,8.0,12.0,24 h after drug administration. The plasma concentration of linezolid was determined by HPLC. The plasma sample was performed the protein precipitation by 10% trichloracetic acid. The mobile phase was methanol-acetonitrile-water(20:20:60, V/ V/ V). The detection wavelength was 254 nm. The pharma- cokinetic parameters were calculated with DAS3.0 software. Results The linear range of linezohd was 0. 20- 40.0 p~g/mL( r =0. 999 3). The average recovery rate was 90.50%-95.20%. Both the within-day and between-day RSD were less than 12%.The main pharmacokinetic parameters were as follows : Cmax (25.36 ±9.65 ) μg/mL, t1/2 (3.72 ± 1.06) h, A UC(o - 24) ( 144. 65 ± 39.85 )mg h/L, AUC(0-∞)) (146.98 ± 45. 18)rag h/L. Conclusion This HPLC method is simple,rapid and suitable for the determination of in vivo linezolid and its pharmaeokinetic study. Linezolid fits to the one- compartment model in Beagle dog in vovo, its elimination is faster and distribution is wider.
Keywords:linezolid  HPLC  pharmacokinetics
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号